BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 21, 2012
View Archived Issues
Quisinostat evaluated in phase II cutaneous T-cell lymphoma trial
Read More
Amicus and GSK report 6-month results from first phase III study of Fabry's disease monotherapy
Read More
Infectex begins phase IIb/III trial of SQ-109
Read More
RaQualia and Lilly to extend research term of ion channel collaboration
Read More
Cempra begins global phase III trial in CABP
Read More
Amgen's AMG-319 tested against lymphoma cells
Read More
Preclinical evidence of a novel dual-acting therapy for diabetes and obesity in nonhuman primates
Read More
PDE inhibitor evaluated in patients with BMD
Read More
Boosting ASO-mediated exon-skipping for the treatment of DMD
Read More
New serotonin 5-HT7 receptor ligands designed by Italian scientists
Read More
PharmaMar recommended to continue ADMYRE trial
Read More
Biogen Idec forms research consortium to develop new ALS treatments
Read More
Medivir reports topline results from phase III simeprevir trials
Read More
New tyrosine kinase inhibitors patented
Read More
The Medicines Company's pivotal SOLO-1 trial meets all endpoints
Read More
Sitavig approved in eight European countries for recurrent labial herpes
Read More
Bayer designs novel TTK protein kinase inhibitors
Read More
Swiss university presents new bombesin receptor ligands
Read More
Novel compounds for IBS patented
Read More
Merck Serono obtains additional indication approval for Erbitux in Japan
Read More
Tredaptive study fails to achieve primary endpoint
Read More
Development of a novel animal model for MLL-rearranged leukemia
Read More
Bayer files additional Japanese application for regorafenib in GIST
Read More
FDA approves Biotest's IVIG for primary humoral immunodeficiency
Read More
Pergamum's phase II trial of DPK-060 in outer ear infections meets endpoints
Read More
